NCT00907400View on ClinicalTrials.gov

Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Naprosyn E

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Healthy

Interventions

DRUG

PN400

oral tablet

DRUG

Naproxen

oral tablet

Trial Locations (2)

Unknown

Research Site, Luleå

Research Site, Uppsala

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY